Crown ZenithCrown Zenith🃏All Zamazenta cards
Ask about Zamazenta V
Zamazenta V #98 Pokémon card from Crown Zenith

Zamazenta V 98/159

Crown Zenith

Find this card on eBay

Affiliate link · we may earn commission

Zamazenta V #98 from Crown Zenith currently trades at $1.41 raw, with PSA 10 copies reaching $34.75 — a 24.6x grade premium.
Current Prices (USD)
Ungraded
$1.41
PSA 7
$5.89
PSA 8
$19.41
PSA 9
$21.00
PSA 10
$34.75
ACE 10
BGS 10 Black
$225.00
CGC 10 Pristine
$44.99
Compare on eBay

Affiliate link · we may earn commission

Quick price facts

Zamazenta V 98/159 from Crown Zenith has a current raw market value of $1.41.

Current raw value
$1.41
PSA 9 value
$21.00
PSA 10 value
$34.75
PSA 10 premium vs raw
24.6× raw
View all cards from Crown Zenith
Collector Intel
24.6x
Raw → PSA 10
High-risk grade
14.9x
Raw → PSA 9
Grade multiplier

Calculated from price history, PSA population data, and market trends. Not financial advice.

Grading Calculator

Based on PSA Standard tier (~$25 USD). Assumes a perfect PSA 10 result — actual outcome depends on card condition.

⚠️ High-variance grade. PSA 10 is 25x the raw price. The expected value accounts for the realistic probability.
$1
Buy Raw
~$25
Grading Fee
PSA Standard
$35
PSA 10 Value
+$8
Best Case (PSA 10)
if you pull a 10
Grade Multiples vs Raw
PSA 9$2114.9x raw
PSA 10$3524.6x raw

Frequently asked questions

How much is Zamazenta V #98 from Crown Zenith worth?+
Zamazenta V #98 from Crown Zenith is currently worth Raw: $1.41, PSA 9: $21.00, PSA 10: $34.75 based on recent sold listings. Prices update daily from real eBay sales.
Is Zamazenta V #98 worth grading?+
The PSA 10 price of $34.75 is 24.6× the raw price of $1.41. After a ~$25 grading fee, a PSA 10 result would net approximately $33.34 — assuming the card grades a 10.
Where do PokePrices Zamazenta V #98 prices come from?+
Prices are tracked nightly from real sold listings on PriceCharting (raw, PSA 9 and PSA 10). PSA population data is sourced from PSA's public reports. We do not use asking prices — only confirmed sales.